Skip to main content

IMC-Chicago, LLC

Position in GILD — Gilead Sciences, Inc.

CIK 1452861 CHICAGO, IL

Position in GILD

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$2,933,109
-$1,935,906 QoQ
Shares Held
23,216
-47.1% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#720
of 2,266 holders
Holding Since
Mar 2020
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in GILD Over Time

Shares Held

Position Value (USD)

Derivatives in GILD

reported options exposure · as of Sep 30, 2021
CallValue
$14,815,185
CallShares
212,100
PutValue
$11,637,010
PutShares
166,600

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

IMC-Chicago, LLC holds $56,648,218 across 9 Drug Manufacturers - General names. GILD ranks #6 (5.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
6 GILD
Gilead Sciences, Inc.
This page
23,216 $2,933,109

All Filings in GILD

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,933,109 23,216
2025-09-30 $4,869,015 43,865
2024-12-31 $5,237,656 56,703
2024-06-30 $2,471,332 36,020
2024-03-31 $4,155,106 56,725
2023-12-31 $6,821,690 84,208
2023-09-30 $4,252,470 56,745
2023-06-30 $4,484,857 58,192
2022-12-31 $21,536,159 250,858
2022-03-31 $3,963,293 66,666
2021-09-30 $11,637,010 166,600
2021-09-30 $14,815,185 212,100
2021-06-30 $1,223,504 17,768
2020-03-31 $11,025,081 147,473